Skip to main content

Table 4 Relative risks for COVID-19 deaths, by risk groups and country

From: Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis

Country Source Sample size Date Risk group Outcome Relative risk (95%CI)
Spain ISCIII 250287 21.05.2020 Cardiovascular disease Death 4.6 (4.6–4.7)
Respiratory disease 3.0 (3.0–3.0)
Diabetes 3.4 (3.4–3.5)
At least one comorbidity 6.6 (6.5–6.6)
France Santé publique France 3784 18.05.2020 Morbid obesity (BMI>40) Death 0.9 (0.6–1.2)
Diabetes 1.3 (1.2–1.5)
Cardiac disease 1.9 (1.7–2.0)
Pulmonary disease 1.5 (1.3–1.7)
Immunodeficiency 1.6 (1.3–1.8)
Renal disease 1.6 (1.4–1.9)
Neuromuscular disorder 2.1 (1.8–2.4)